Trial Profile
Efficacy of nonavalent vaccine against human papilloma virus (HPV ) in HIV infected sexually active men who have sex with men (MSM)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2019
Price :
$35
*
At a glance
- Drugs V 503 (Primary)
- Indications Human papillomavirus infections
- Focus Therapeutic Use
- Acronyms HPV-VAX
- 31 Aug 2019 Status changed from recruiting to discontinued.
- 19 Apr 2016 New trial record